Skip to Main content Skip to Navigation
Journal articles

Enhancement of Adjuvant Functions of Natural Killer T Cells Using Nanovector Delivery Systems: Application in Anticancer Immune Therapy

Abstract : Type I natural killer T (NKT) cells have gained considerable interest in anticancer immune therapy over the last decade. This "innate-like" T lymphocyte subset has the unique ability to recognize foreign and self-derived glycolipid antigens in association with the CD1d molecule expressed by antigen-presenting cells. An important property of these cells is to bridge innate and acquired immune responses. The adjuvant function of NKT cells might be exploited in the clinics. In this review, we discuss the approaches currently being used to target NKT cells for cancer therapy. In particular, we highlight ongoing strategies utilizing NKT cell-based nanovaccines to optimize immune therapy.
Document type :
Journal articles
Complete list of metadatas

Cited literature [81 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02436032
Contributor : François Trottein <>
Submitted on : Tuesday, January 14, 2020 - 2:12:19 PM
Last modification on : Thursday, April 9, 2020 - 1:47:46 AM

File

Enhancement_of_adjuvant_fuunct...
Publication funded by an institution

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Collections

Citation

Reem Ghinnagow, Luis Javier Cruz, Elodie Macho-Fernandez, Christelle Faveeuw, François Trottein. Enhancement of Adjuvant Functions of Natural Killer T Cells Using Nanovector Delivery Systems: Application in Anticancer Immune Therapy. Frontiers in Immunology, Frontiers, 2017, 8, pp.879. ⟨10.3389/fimmu.2017.00879⟩. ⟨inserm-02436032⟩

Share

Metrics

Record views

92

Files downloads

190